Target intelligence / Profile preview

Ankyrin repeat domain-containing protein 24 (ANKRD24)

Target
ANKRD24
Molecular classification
Other (Ankyrin repeat domain-containing protein; not classified as receptor, enzyme, transporter, etc.)
01

Overview

Ankyrin repeat domain-containing protein 24 (ANKRD24) is a large intracellular protein characterized by multiple ankyrin repeat domains, which are known for mediating protein-protein interactions[1][7][8]. ANKRD24 is primarily expressed in the inner ear, where it is localized to the rootlets of hair cell stereocilia and is essential for their structural integrity[2][3][4][5][7]. It physically surrounds and binds TRIOBP-5, a critical actin-bundling protein, thereby anchoring stereocilia to the cuticular plate and helping to protect the hair bundle from overstimulation and noise-induced damage[2][3]. Disruption of ANKRD24 in mice results in progressive hearing loss and reduced recovery from auditory trauma[3]. Beyond the auditory system, altered expression of ANKRD24 has been recognized as part of prognostic gene signatures in neuroblastoma and is upregulated in certain cancers, suggesting a potential biomarker role[2]. Despite its well-defined structural role in the ear, no current evidence supports its classification as a therapeutic target, receptor, enzyme, or transporter; it is best considered a scaffold protein with disease relevance as a biomarker[1][2][3][7][8].

Other names
Ankyrin repeat domain 24KIAA1981ankyrin repeat domain-containing protein 24ANKRD24
02

Biological functions

Actin bindingOrganization of auditory receptor cell stereociliumSensory perception of soundProtein-protein interaction scaffold
03

Disease associations

Hearing loss (genetic mutations disrupt rootlet structure, causing progressive hearing loss)Prognostic biomarker (implicated in neuroblastoma as part of multi-gene signatures)Potential roles in cancers (noted increased expression in certain cancers including germ line tumors, glioma, and prostate cancer)
04

Biomarkers

Prognostic biomarker in neuroblastoma (RNA-based multi-gene risk stratification)

Beyond the preview

Go deeper on Ankyrin repeat domain-containing protein 24 (ANKRD24).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ankyrin repeat domain-containing protein 24 (ANKRD24).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call